Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol and/or Chlorpromazine for Refractory Agitated Delirium in Advanced Cancer
NCT03021486Phase 3Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2017
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of haloperidol, Aminazin in delirium, sponsored by University of Texas MD Anderson Cancer Center. Started Jun 2017; status: active, not recruiting.
02
Drugs
haloperidolAminazin
03
Conditions
delirium
Beyond the preview
Go deeper on NCT03021486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03021486.